Clover Health Investments, Corp. - Class A Common stock (CLOV)
3.7200
+0.0800 (2.20%)
Clover Health Investments Corp is a healthcare technology company focused on improving the health outcomes of Medicare beneficiaries
By utilizing its proprietary data-driven platform, Clover Health aims to enhance care delivery and streamline operations for its members, promoting preventive care and tailored health services. The company partners with healthcare providers to deliver more efficient and personalized care, ultimately seeking to reduce costs and improve patient satisfaction in the healthcare system. Through innovation and technology, Clover Health strives to make healthcare more accessible and effective for seniors across the United States.

Stocks recovered on Friday, with all three major indexes in the green, as the tech sector bounced back from Thursday's losses with NVIDIA Corp. (NASDAQNVDA) up 1.37% and Tesla, Inc. NASDAQ:TSLANASDAQTSLA)
Via Benzinga · February 28, 2025

Health insurance company Clover Health (NASDAQCLOV) missed Wall Street’s revenue expectations in Q4 CY2024, with sales falling 34% year on year to $337 million. Its GAAP loss of $0.04 per share was $0.03 above analysts’ consensus estimates.
Via StockStory · February 27, 2025

The S&P 500 and Nasdaq both slipped into the red, reversing early gains on Thursday, while the Dow Jones remained in positive territory in midday trading.
Via Benzinga · February 27, 2025

Via Benzinga · December 10, 2024

Health insurance company Clover Health (NASDAQCLOV) will be reporting results tomorrow afternoon. Here’s what to look for.
Via StockStory · February 26, 2025

Cramer says people believe AMD "will not be able to deliver on this quarter" and so he's reluctant to get in.
Via Benzinga · January 22, 2025
Here are a variety of lesser-known charts from my “Recents” watch list. Quite a few of them look like good bullish plays.
Via Talk Markets · November 30, 2024

Trump's second term could bring significant changes to U.S. healthcare, with cuts to ACA subsidies and potential Medicare privatization.
Via Benzinga · November 9, 2024

Via Benzinga · October 25, 2024

Via Benzinga · October 3, 2024

Via Benzinga · September 9, 2024

Via Benzinga · November 7, 2024

Via Benzinga · November 7, 2024

AbbVie Inc., which split from Abbott Laboratories remains more than a decade ago, is doing "very, very well," Jim Cramer says.
Via Benzinga · October 17, 2024

Clover Health Investments shares are trading higher by 4.6% Friday afternoon. The company announced that CMS raised its PPO Medicare Advantage plans' Star rating to 4 Stars for 2025.
Via Benzinga · October 11, 2024

U.S. indices closed Wednesday in positive territory, with the Dow Jones Industrial Average increasing by 0.09% to 42,196.52.
Via Benzinga · October 2, 2024

Clover Health Investments shares are trading higher Wednesday amid increased trading volume and gaining traction across social media platforms. Here's what you need to know.
Via Benzinga · October 2, 2024

Via Benzinga · October 2, 2024

Via Benzinga · October 2, 2024

Short reports can be crippling for a stock in the short term, but what about the longer run?
Via The Motley Fool · September 10, 2024

Clover Health stock is moving higher Wednesday after the company's subsidiary, Counterpart Health, announced a multi-year agreement with Iowa Clinic.
Via Benzinga · September 4, 2024

Via Benzinga · September 4, 2024

Clover Health Investments Corp shares are trading higher in extended trading Tuesday after one of the company's subsidiaries announced a multi-year agreement with The Iowa Clinic.
Via Benzinga · September 3, 2024